How I understand the situation, the MD Peter Rowe has sold most of his stock to George Cameron Dow, who originates from South Africa and has been involved with large corporations, most notably in the pharmaceutical industry. George was/is a director of biotech stock Southport and was involved with its backdoor listing, which was favourably received by the market. This may give an indication of where ADM is heading.
The new regime is well connected in the business world and I expect them to do something with this stock, what Peter Rowe was unable to achieve - all credit to Peter for finally relinquishing the ropes in the interests of long suffering shareholders. We have already seen anticipation of a new positive direction in the stock price.
